UnitedHealth EVP gets dividend-equivalent share award

UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award.

Rhea-AI Filing Summary

UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units at a stated price of $0.00 per share.

These dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this award, McSweeney directly holds a reported total of 15,552.923 UnitedHealth Group common shares.

Insider Trade Summary

Grant/Award: 64.885 shares

Grant/Award 1 txn

Insider McSweeney Erin

Role EVP & Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	64.885	$0.00	$0.00

Holdings After Transaction: Common Stock — 15,552.923 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UnitedHealth (UNH) report for Erin McSweeney?

Erin McSweeney reported an acquisition of UnitedHealth common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units, with no cash purchase price, increasing her directly held stake in the company.

How many UnitedHealth (UNH) shares does Erin McSweeney hold after this Form 4?

After this reported transaction, Erin McSweeney directly holds 15,552.923 UnitedHealth common shares. This total includes the 64.885 shares received as dividend equivalents on restricted stock units, which follow the same vesting conditions as the underlying units.

What is the nature of the 64.885 UnitedHealth (UNH) shares granted to Erin McSweeney?

The 64.885 UnitedHealth shares represent dividend equivalents on outstanding restricted stock units held by Erin McSweeney. They are not a cash purchase, carry a stated price of $0.00, and are subject to the same vesting and forfeiture conditions as the related restricted stock units.

Are the dividend equivalent shares to Erin McSweeney in UnitedHealth (UNH) fully vested?

The dividend equivalent shares are not automatically fully vested. They are subject to the same vesting schedule and conditions as the underlying restricted stock units and will be forfeited if those units ultimately fail to vest, aligning their treatment with the original equity awards.

Does Erin McSweeney’s UnitedHealth (UNH) Form 4 show an open-market stock purchase or sale?

The Form 4 does not show an open-market purchase or sale. It reports a grant-type acquisition coded as a dividend equivalent award on restricted stock units, with a transaction price of $0.00 per share, rather than a trade executed in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McSweeney Erin

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief People Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		64.885(1)	A	$0	15,552.923	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Erin L. McSweeney	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)